Accueil>>Signaling Pathways>> Metabolism>> phosphatases>>BN82002

BN82002

Catalog No.GC33345

Le BN82002 est un inhibiteur puissant, sélectif et irréversible de la famille des phosphatases CDC25. BN82002 inhibe CDC25A, CDC25B2, CDC25B3, CDC25C CDC25A et 25C-cat avec des valeurs IC50 de 2,4, 3,9, 6,3, 5,4 et 4,6 μM, respectivement. BN82002 affiche une sélectivité environ 20 fois supérieure À celle de la tyrosine phosphatase CD45.

Products are for research use only. Not for human use. We do not sell to patients.

BN82002 Chemical Structure

Cas No.: 396073-89-5

Taille Prix Stock Qté
10mM (in 1mL DMSO)
111,00 $US
En stock
5mg
101,00 $US
En stock
10mg
138,00 $US
En stock
50mg
414,00 $US
En stock
100mg
689,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

BN82002 is a synthetic inhibitor of CDC25 phophatases, with IC50s of 2.4-6.3 μM for recombinant CDC25 phosphatases.

The effect of BN82002 on cell proliferation is evaluated in vitro on several human tumor cell lines. Menadione, which has been reported to inhibit cell proliferation, is used as a control. All of the examined cell lines are sensitive to BN82002 and Menadione in a concentration-dependent manner in the low micromolar range. The most sensitive is the pancreatic cancer cell line MIA PaCa-2 with an IC50 of 7.2 μM, and the less sensitive cell line is the colon cancer HT-29 with an IC50 of 32.6 μM. The range of activity is very similar to the one observed with menadione (5-15 μM). It is also showed that 50 μM BN82002 is a concentration that fully inhibits cell proliferation, the cell cycle distribution is only modestly affected with a slight decrease in S phase and an increase in cells containing both a G1 and a G2 DNA content, suggesting that the cells treated with BN82002 are arrested at various stages of the cell cycle[1].

[1]. Brezak MC, et al. A novel synthetic inhibitor of CDC25 phosphatases: BN82002. Cancer Res. 2004 May 1;64(9):3320-5.

Avis

Review for BN82002

Average Rating: 5 ★★★★★ (Based on Reviews and 29 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for BN82002

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.